L'ospedale San Donato di Arezzo è la più grande struttura sanitaria della provincia di Arezzo. Presso l'ospedale ha sede il Polo universitario aretino dell'Università degli Studi di Siena, con attivi ...

During the past decade, Ospedale San Donato conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 16 clinical trials were completed, i.e. on average, 41% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 7 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Donato" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "AVEO Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Donato" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Foundation Medicine" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Ospedale San Donato" with 2 trials as a collaborator and "ANìMO (National Association of Hospital Medicine Nurses)" with 1 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Donato" are "Renal Cell Carcinoma" (5 trials), "Atrial Fibrillation" (4 trials), "Bladder Cancer" (4 trials), "Acute Coronary Syndrome" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Ospedale San Donato" in a lesser frequency.

Most popular intervention types in "Ospedale San Donato" are "Drug" (43 trials), "Procedure" (9 trials), "Device" (8 trials), "Other" (8 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Docetaxel" (5 trials), "Placebo" (5 trials), "Paclitaxel" (3 trials) and "Vinflunine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Donato" are 62 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale San Donato". undefined are not yet recruiting, 9 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 37 completed trials in Ospedale San Donato, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Donato, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".